Thyroid Eye Disease Patients Gain First At-Home Injection Option as FDA Clears Roche’s Enspryng for Adults

The FDA approved Roche’s Enspryng for thyroid eye disease, the first treatment patients or caregivers can inject at home every four weeks.

Have A Referral?